Melanoma : the new biotherapeutics for solid tumors /
Saved in:
Imprint: | Totowa, N.J. : Humana Press, c2002. |
---|---|
Description: | xvi, 389 p. : ill. (some col.) ; 24 cm. |
Language: | English |
Series: | Current clinical oncology Current clinical oncology (Totowa, N.J.) |
Subject: | |
Format: | Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4719783 |
Table of Contents:
- Introduction
- Contributors
- I. Perspective on the Clinical Disease
- 1. Management of Primary Malignant Melanoma
- 2. A Pathologist's Perspective on Prognostic Features of Malignant Melanoma
- 3. Clinical Prognostic Factors and Staging
- II. Biological and Targeted Therapeutics
- 4. Principles of Antitumor Immunity and Tumor-Mediated Immunosuppression
- 5. Immunotherapy of Advanced Melanoma Directed at Specific Antigens
- 6. Melanoma Antigens: Vaccines and Monoclonal Antibodies
- 7. Interleukin-2
- 8. Interleukin-12: Immunologic and Antitumor Effects in Human Malignant Melanoma
- 9. Interferons: Preclinical and Clinical Studies in Melanoma
- 10. Biochemotherapy of Melanoma
- 11. Signal Transduction Abnormalities as Therapeutic Targets
- 12. Tumor Angiogenesis
- 13. Antiangiogenic Therapy for Melanoma
- Index